[1]张雅楠 许锋.心脏脱细胞基质水凝胶制备及其对心肌梗死修复的研究进展[J].心血管病学进展,2023,(9):823.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.013]
　ZHANG Yanan,XU Feng.Preparation of Cardiac Decellularized Extracellular Matrix Hydrogel and Its Application in Myocardial Infarction Repair[J].Advances in Cardiovascular Diseases,2023,(9):823.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.013]
点击复制

心脏脱细胞基质水凝胶制备及其对心肌梗死修复的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年9期
页码:
823
栏目:
综述
出版日期:
2023-09-25

文章信息/Info

Title:
Preparation of Cardiac Decellularized Extracellular Matrix Hydrogel and Its Application in Myocardial Infarction Repair
作者:
张雅楠1 许锋1; 2
(1.广西医科大学 再生医学与医用生物资源开发应用协同创新中心 广西再生医学重点实验室,广西 南宁 530021;2.上海交通大学 上海交通大学医学院附属第九人民医院,上海 200011)
Author(s):
ZHANG Yanan1; XU Feng1; 2
(1. Guangxi Medical University,Collaborative Innovation Center of Regenerative Medicine and Medical Biological Resources Development and Application,Guangxi Key Laboratory of Regenerative Medicine,Nanning 530021Guangxi,China2. Shanghai Jiao Tong University, Shanghai Ninth Peoples Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200011,China)
关键词:
脱细胞基质; 可注射水凝胶; 心肌梗死; 心脏修复; 再生医学
Keywords:
Decellularized extracellular matrix; Injectable hydrogel; Myocardial infarction; Cardiac repair; Regenerative medicine
DOI:
10.16806/j.cnki.issn.1004-3934.2023.09.013
摘要:
心肌组织通过物理、化学或其他方法进行脱细胞处理后，制备成的脱细胞基质含有许多细胞外基质成分，包括蛋白质、胶原、多糖以及生长因子等，不仅对细胞生长有很好的生物相容性，而且还能有助于细胞的再生和修复，是一种很有前途的心血管修复材料。脱细胞基质水凝胶是将脱细胞基质进行凝胶化后，所形成的一种具有生物相容性、可降解性以及可注射性的生物材料，不仅保留了脱细胞基质本身的优点，而且增加了可注射性这一优势，可在心肌梗死后进行微创注射，从而对心脏产生修复作用。
Abstract:
After decellularization of myocardial tissue by physical,chemical or other methods,the prepared decellularized matrix contains many extracellular matrix components, the prepared decellularized extracellular matrix(dECM) contains many extracellular matrix components,including proteins,collagen,polysaccharides and growth factors. ?It not only has good biocompatibility for cell growth,but also contributes to cell regeneration and repair,which is a promising material for cardiovascular repair. dECM hydrogel is a biocompatible,degradable and injectable biological material formed after gelling the dECM,which not only retains the advantages of the dECM itself but also increases the advantage of injectability,and can be minimally invasive injection after myocardial infarction,thereby having a repair effect on the heart.

参考文献/References:

[1] Tsao CW,Aday AW,Almarzooq ZI,et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association [J]. Circulation,2022,145(8): e153-e639.

[2] Swynghedauw B. Molecular mechanisms of myocardial remodeling[J]. Physiol Rev,1999,79(1):215-262.

[3] Taylor DA,Sampaio LC,Ferdous Z,et al. Decellularized matrices in regenerative medicine[J]. Acta Biomater,2018,74: 74-89.

[4] Zhang X,Chen X,Hong H,et al. Decellularized extracellular matrix scaffolds:Recent trends and emerging strategies in tissue engineering[J]. Bioact Mater,2022,10:15-31.

[5] Ferdowsi Khosroshahi A,Soleimani Rad J, Kheirjou R,et al. Adipose tissue-derived stem cells upon decellularized ovine small intestine submucosa for tissue regeneration:An optimization and comparison method[J]. J Cell Physiol,2020,235(2):1556-1567.

[6] Yusof F,Sha’Ban M,Azhim A. Development of decellularized meniscus using closed sonication treatment system: potential scaffolds for orthopedics tissue engineering applications [J]. Int J Nanomedicine,2019,14:5491-5502.

[7] Nakamura N,Kimura T,Kishida A. Overview of the development, applications,and future perspectives of decellularized tissues and organs[J]. ACS Biomater Sci Eng,2017,3(7):1236-1244.

[8] Gupta SK,Mishra NC,Dhasmana A. Decellularization methods for scaffold fabrication[J]. Methods Mol Biol,2018, 1577:1-10.

[9] Paulo Zambon J,Atala A,YOO JJ. Methods to generate tissue-derived constructs for regenerative medicine applications[J]. Methods,2020,171:3-10.

[10] Ott HC,Matthiesen TS,Goh SK,et al. Perfusion-decellularized matrix:using nature’s platform to engineer a bioartificial heart[J]. Nat Med,2008, 14(2):213-221.

[11] Bai R,Tian L,Li Y,et al. Combining ECM hydrogels of cardiac bioactivity with stem cells of high cardiomyogenic potential for myocardial repair[J]. Stem Cells Int,2019,2019:6708435.

[12] Shi Q,Chen Y,Li M,et al. Designing a novel vacuum aspiration system to decellularize large-size enthesis with preservation of physicochemical and biological properties[J]. Ann Transl Med,2020,8(21):1364.

[13] Wang Z,Sun F,Lu Y,et al. Rapid preparation method for preparing tracheal decellularized scaffolds: vacuum assistance and optimization of DNase I[J]. ACS Omega,2021,6(16):10637-10644.

[14] Nguyen DT,O’hara M,Graneli C,et al. Humanizing miniature hearts through 4-flow cannulation perfusion decellularization and recellularization[J]. Sci Rep,2018,8(1):7458.

[15] Wang X,Ansari A,Pierre V,et al. Injectable extracellular matrix microparticles promote heart regeneration in mice with post-ischemic heart injury[J]. Adv Healthc Mater,2022,11(8):e2102265.

[16] Tsui JH,Leonard A,Camp ND,et al. Tunable electroconductive decellularized extracellular matrix hydrogels for engineering human cardiac microphysiological systems[J]. Biomaterials,2021,272:120764.

[17] Gómez-cid L,López-donaire ML,Velasco D,et al. Cardiac extracellular matrix hydrogel enriched with polyethylene glycol presents improved gelation time and increased on-target site retention of extracellular vesicles[J]. Int J Mol Sci,2021,22(17):9226.

[18] Wang X,Pierre V,Liu C,et al. Exogenous extracellular matrix proteins decrease cardiac fibroblast activation in stiffening microenvironment through CAPG[J]. J Mol Cell Cardiol,2021,159:105-119.

[19] Wang X,Pierre V,Senapati S,et al. microenvironment stiffness amplifies post-ischemia heart regeneration in response to exogenous extracellular matrix proteins in neonatal mice[J]. Front Cardiovasc Med,2021,8:773978.

[20] Huang K,Ozpinar EW,Su T,et al. An off-the-shelf artificial cardiac patch improves cardiac repair after myocardial infarction in rats and pigs [J]. Sci Transl Med,2020,12(538):eaat9683.

[21] Mendibil U,Ruiz-Hernandez R,Retegi-Carrion S,et al. Tissue-specific decellularization methods:rationale and strategies to achieve regenerative compounds[J]. Int J Mol Sci,2020,21(15):5447.

[22] Costa A,Naranjo JD,Londono R,et al. Biologic Scaffolds[J]. Cold Spring Harb Perspect Med,2017,7(9):a025676.

[23] Singelyn JM,DeQuach JA,Seif-Naraghi SB,et al. Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering[J]. Biomaterials,2009,30(29):5409-5416.

[24] Singelyn JM,Sundaramurthy P,Johnson TD,et al. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction[J]. J Am Coll Cardiol,2012,59(8):751-763.

[25] Mousavi A,Mashayekhan S,Baheiraei N,et al. Biohybrid oxidized alginate/myocardial extracellular matrix injectable hydrogels with improved electromechanical properties for cardiac tissue engineering[J]. Int J Biol Macromol,2021,180:692-708.

[26] Curley CJ,Dolan EB,Otten M,et al. An injectable alginate/extra cellular matrix (ECM) hydrogel towards acellular treatment of heart failure[J]. Drug Deliv Transl Res,2019,9(1):1-13.

[27] Chen P,Wang L,Fan X,et al. Targeted delivery of extracellular vesicles in heart injury[J].Theranostics,2021,11(5):2263-2277.

[28] Reis LA,Chiu LL,Feric N,et al. Biomaterials in myocardial tissue engineering[J]. J Tissue Eng Regen Med,2016,10(1):11-28.

[29] Ullah I,Busch JF,Rabien A,et al. Adult tissue extracellular matrix determines tissue specification of human iPSC-derived embryonic stage mesodermal precursor cells[J]. Adv Sci (Weinh),2020,7(5):1901198.

[30] Rajabi S,Pahlavan S,Ashtiani MK,et al. Human embryonic stem cell-derived cardiovascular progenitor cells efficiently colonize in bFGF-tethered natural matrix to construct contracting humanized rat hearts[J]. Biomaterials,2018,154:99-112.

[31] Qian Z,Sharma D,Jia W,et al. Engineering stem cell cardiac patch with microvascular features representative of native myocardium[J]. Theranostics,2019,9(8):2143-2157.

[32] Diaz MD,Tran E,Spang M,et al. Injectable myocardial matrix hydrogel mitigates negative left ventricular remodeling in a chronic myocardial infarction model[J]. JACC Basic Transl Sci,2021,6(4):350-361.

[33] Wang X,Senapati S,Akinbote A,et al. Microenvironment stiffness requires decellularized cardiac extracellular matrix to promote heart regeneration in the neonatal mouse heart[J]. Acta Biomater,2020,113:380-392.

[34] Wang Z,Long DW,Huang Y,et al. Decellularized neonatal cardiac extracellular matrix prevents widespread ventricular remodeling in adult mammals after myocardial infarction[J]. Acta Biomater,2019,87:140-151.

[35] Traverse JH,Henry TD,Dib N,et al. First-in-man study of a cardiac extracellular matrix hydrogel in early and late myocardial infarction patients[J]. JACC Basic Transl Sci,2019,4(6):659-669.

[36] Waters R,Alam P,Pacelli S,et al. Stem cell-inspired secretome-rich injectable hydrogel to repair injured cardiac tissue[J]. Acta Biomater,2018,69:95-106.

[37] Zhu D,Li Z,Huang K,et al. Minimally invasive delivery of therapeutic agents by hydrogel injection into the pericardial cavity for cardiac repair[J]. Nat Commun,2021,12(1):1412.

[38] 蒋永生,李锐,韩春婵,等. 脱细胞基质水凝胶促组织再生的研究进展[J]. 中国生物医学工程学报,2021 ,5:628-635.

[39] Yan J,Xu Y. Preparation and application of decellularized extracellular matrix bioink:a review[J]. Sheng Wu Gong Cheng Xue Bao,2021,37(11):4024-4035.

[40] Shin YJ,Shafranek RT,Tsui JH,et al. 3D bioprinting of mechanically tuned bioinks derived from cardiac decellularized extracellular matrix[J]. Acta Biomater,2021,119:75-88.

[41] Das S,Kim SW,Choi YJ,et al. Decellularized extracellular matrix bioinks and the external stimuli to enhance cardiac tissue development in vitro[J]. Acta Biomater,2019,95:188-200.

[42] Yu C,Ma X,Zhu W,et al. Scanningless and continuous 3D bioprinting of human tissues with decellularized extracellular matrix[J]. Biomaterials,2019,194:1-13.

相似文献/References:

[1]陈广 文英 蒋学俊.可注射水凝胶在心肌梗死中的应用与进展[J].心血管病学进展,2023,(1):62.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.015]
　CHEN Guang,WEN Ying,J IANG Xuejun.Application and Progress of Injectable Hydrogel in Myocardial Infarction[J].Advances in Cardiovascular Diseases,2023,(9):62.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.015]

更新日期/Last Update: 2023-10-17